These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 34299496)

  • 1. Preclinical Testing of Radiopharmaceuticals for the Detection and Characterization of Osteomyelitis: Experiences from a Porcine Model.
    Alstrup AKO; Jensen SB; Nielsen OL; Jødal L; Afzelius P
    Molecules; 2021 Jul; 26(14):. PubMed ID: 34299496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic Modelling of [
    Jødal L; Roivainen A; Oikonen V; Jalkanen S; Hansen SB; Afzelius P; Alstrup AKO; Nielsen OL; Jensen SB
    Molecules; 2019 Nov; 24(22):. PubMed ID: 31766140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic Modelling of Infection Tracers [
    Jødal L; Jensen SB; Nielsen OL; Afzelius P; Borghammer P; Alstrup AKO; Hansen SB
    Contrast Media Mol Imaging; 2017; 2017():9256858. PubMed ID: 29114181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attempts to Target
    Afzelius P; Alstrup AKO; Nielsen OL; Nielsen KM; Jensen SB
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32967275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET tracer development--a tale of mice and men.
    Hicks RJ; Dorow D; Roselt P
    Cancer Imaging; 2006 Oct; 6(Spec No A):S102-6. PubMed ID: 17114061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How many PET tracers do we need?
    Schwaiger M; Wester HJ
    J Nucl Med; 2011 Dec; 52 Suppl 2():36S-41S. PubMed ID: 22144553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of 18F-FDG and 68Ga PET imaging in the assessment of experimental osteomyelitis due to Staphylococcus aureus.
    Mäkinen TJ; Lankinen P; Pöyhönen T; Jalava J; Aro HT; Roivainen A
    Eur J Nucl Med Mol Imaging; 2005 Nov; 32(11):1259-68. PubMed ID: 16007423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron Emission Tomography (PET) Radiopharmaceuticals in Multiple Myeloma.
    Sachpekidis C; Goldschmidt H; Dimitrakopoulou-Strauss A
    Molecules; 2019 Dec; 25(1):. PubMed ID: 31905752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animal tumor models for PET in drug development.
    Toyohara J; Ishiwata K
    Ann Nucl Med; 2011 Dec; 25(10):717-31. PubMed ID: 21879295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ramatroban-Based Analogues Containing Fluorine Group as Potential
    Huang LA; Huang KX; Tu J; Kandeel F; Li J
    Molecules; 2021 Mar; 26(5):. PubMed ID: 33800801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET and SPECT Tracers for Myocardial Perfusion Imaging.
    Klein R; Celiker-Guler E; Rotstein BH; deKemp RA
    Semin Nucl Med; 2020 May; 50(3):208-218. PubMed ID: 32284107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron emission tomographic imaging in drug discovery.
    Ghosh KK; Padmanabhan P; Yang CT; Ng DCE; Palanivel M; Mishra S; Halldin C; Gulyás B
    Drug Discov Today; 2022 Jan; 27(1):280-291. PubMed ID: 34332093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The accuracy of diagnostic imaging for the assessment of chronic osteomyelitis: a systematic review and meta-analysis.
    Termaat MF; Raijmakers PG; Scholten HJ; Bakker FC; Patka P; Haarman HJ
    J Bone Joint Surg Am; 2005 Nov; 87(11):2464-71. PubMed ID: 16264122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficiency gains in tracer identification for nuclear imaging: can in vivo LC-MS/MS evaluation of small molecules screen for successful PET tracers?
    Joshi EM; Need A; Schaus J; Chen Z; Benesh D; Mitch C; Morton S; Raub TJ; Phebus L; Barth V
    ACS Chem Neurosci; 2014 Dec; 5(12):1154-63. PubMed ID: 25247893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell functionality testing is highly relevant to developing novel immuno-tracers monitoring T cells in the context of immunotherapies and revealed CD7 as an attractive target.
    Mayer KE; Mall S; Yusufi N; Gosmann D; Steiger K; Russelli L; Bianchi HO; Audehm S; Wagner R; Bräunlein E; Stelzl A; Bassermann F; Weichert W; Weber W; Schwaiger M; D'Alessandria C; Krackhardt AM
    Theranostics; 2018; 8(21):6070-6087. PubMed ID: 30613283
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Chaney A; Cropper HC; Johnson EM; Lechtenberg KJ; Peterson TC; Stevens MY; Buckwalter MS; James ML
    J Nucl Med; 2019 Jan; 60(1):122-128. PubMed ID: 29976695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET imaging of demyelination and remyelination in the cuprizone mouse model for multiple sclerosis: a comparison between [11C]CIC and [11C]MeDAS.
    de Paula Faria D; de Vries EF; Sijbesma JW; Dierckx RA; Buchpiguel CA; Copray S
    Neuroimage; 2014 Feb; 87():395-402. PubMed ID: 24188813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CMKLR1-targeting peptide tracers for PET/MR imaging of breast cancer.
    Erdmann S; Niederstadt L; Koziolek EJ; Gómez JDC; Prasad S; Wagener A; von Hacht JL; Reinicke S; Exner S; Bandholtz S; Beindorff N; Brenner W; Grötzinger C
    Theranostics; 2019; 9(22):6719-6733. PubMed ID: 31588246
    [No Abstract]   [Full Text] [Related]  

  • 20. PET tracers based on (86)Y.
    Huang J; Cui L; Wang F; Liu Z
    Curr Radiopharm; 2011 Apr; 4(2):122-30. PubMed ID: 22191651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.